Description
GH Stack 5/5mg Core Metrics
Technical specification parameters optimized for tracking dual-action growth factor signaling variables simultaneously.
| Operational Engine | Assay Benchmark Profile | Internal Catalog Link |
|---|---|---|
| 1:1 Ratio Synchronization | Pre-mixed equimolar solid cake blocks manual pipetting variance and cross-contamination errors. | High-Purity Series → |
| Purity Standard | ≥ 98% via High-Resolution SEC-HPLC Matrix | Muscle Growth Series → |
What Is the CJC-1295 Ipamorelin GH Stack?
The CJC-1295 Ipamorelin GH Stack is a powerful 1:1 synergistic secretagogue formulation designed to maximize endogenous Growth Hormone (GH) release through dual pathway stimulation. By combining CJC-1295 No DAC (a potent 29-amino-acid GHRH analog also known as Mod GRF 1-29) with Ipamorelin (a selective pentapeptide ghrelin receptor agonist), this blend activates two distinct neuroendocrine receptors simultaneously.
In analytical endocrinology and metabolic research, our GH Stack 10mg presentation serves as a premier reference standard. Supplying a combined 10mg lyophilized vial provides laboratories with optimal material yield for concentration titration series, receptor binding assays, and pulse-frequency profiling without batch variance. To review batch-specific HPLC purity documentation and third-party laboratory reports, visit peptidesk.com.
| Parameter | Specification Standard |
|---|---|
| Product Format | 10mg Total Formulation (5mg CJC-1295 No DAC / 5mg Ipamorelin) |
| Purity Baseline | ≥ 98.0% Certified via HPLC Assays (99% Purity Standard) |
| Active Ingredients | Mod GRF(1-29) + Ipamorelin Pentapeptide |
| Physical Appearance | Sterile filtered, white lyophilized cake |
| Primary Receptors Target | GHRH Receptor + GHSR-1a (Ghrelin Receptor) |
How Much CJC-1295 and Ipamorelin Is in a 10mg GH Stack?
To guarantee precise stoichiometry during analytical testing, every vial of our CJC-1295 Ipamorelin 10mg blend is calibrated under strict mass-spectrometry control. The exact CJC-1295 No DAC 5mg + Ipamorelin 5mg ratio provides an ideal 1:1 molar synergy:
| Component Peptide | Quantity per Vial | Target Receptor & Function |
|---|---|---|
| CJC-1295 No DAC (Mod GRF 1-29) | 5 mg | Binds GHRH receptor; stimulates production and pulse amplitude of GH in anterior pituitary somatotropes. |
| Ipamorelin | 5 mg | Binds GHSR-1a; inhibits Somatostatin (GH-inhibiting hormone) and amplifies GH pulse volume without spiking cortisol/prolactin. |
How Does the CJC-1295 Ipamorelin GH Stack Work?
When administered individually, GHRH analogs and Ghrelin agonists stimulate modest growth hormone pulses. However, combining them in a single CJC Ipamorelin blend produces a powerful supra-additive effect on growth hormone release.
The cellular mechanism relies on simultaneous intracellular signaling cascades:
- GHRH Pathway Activation: CJC-1295 No DAC binds to the GHRH receptor, triggering adenylate cyclase activation and elevating intracellular cAMP levels.
- GHSR-1a Pathway Activation: Ipamorelin binds the GHSR-1a receptor, activating the Phospholipase C (PLC) pathway to increase intracellular calcium ($Ca^{2+}$) mobilization.
- Somatostatin Suppression: Ipamorelin suppresses localized Somatostatin release (the brake on GH release), allowing the CJC-1295 signal to drive maximum somatotroph exocytosis.
How Does a GH Stack With CJC-1295 and Ipamorelin Affect Growth Hormone Release?
Rather than elevating baseline growth hormone continuously (which can induce receptor desensitization and insulin resistance), the CJC-1295 Ipamorelin combination mimics natural, youthful pulsatile GH release.
Research indicates that the synergistic peak release from a dual GH stack is significantly greater than the mathematical sum of both peptides administered separately. This produces clean, high-amplitude secretagogue pulses that decay naturally back to baseline levels, preserving physiological pituitary function.
What Is the Difference Between CJC-1295 and Ipamorelin in a GH Stack?
Understanding the distinction between these two components is key to evaluating CJC Ipamorelin 10mg data:
| Feature | CJC-1295 No DAC | Ipamorelin |
|---|---|---|
| Peptide Class | Growth Hormone-Releasing Hormone (GHRH) Mimetic | Growth Hormone Secretagogue (GHRP / Ghrelin Agonist) |
| Primary Action | Signals pituitary cells to synthesize and release GH | Suppresses Somatostatin and potentiates GH pulse height |
| Off-Target Effects | Zero ghrelin-induced hunger surges | Selective; no stimulation of Cortisol or Prolactin |
What Is CJC-1295 No DAC and Why Is It Used in GH Stacks?
CJC-1295 No DAC (without Drug Affinity Complex) is a modified form of natural GHRH(1-29) with four amino acid substitutions that protect the peptide against rapid enzymatic cleavage by Dipeptidyl Peptidase IV (DPP-IV). Unlike CJC-1295 With DAC (which binds serum albumin and remains active for days), CJC-1295 No DAC exhibits a half-life of roughly 30 minutes.
This shorter half-life is specifically preferred in a CJC-1295 Ipamorelin blend because it induces sharp, natural pulses of GH rather than chronic, continuous elevation. Continuous GH elevation can desensitize pituitary receptors and impair blood glucose homeostasis, making No DAC the ideal research candidate for physiological pulsatile studies.
Does the CJC-1295 Ipamorelin GH Stack Affect the GH/IGF-1 Axis?
Yes. Elevated GH secretion driven by the stack travels via systemic circulation to hepatocytes in the liver, where it stimulates the transcription and release of Insulin-like Growth Factor 1 (IGF-1). The GH/IGF-1 axis is the master regulator of cellular repair, protein synthesis, lipolysis, and nitrogen retention.
By augmenting endogenous GH pulse amplitude, the secretagogue combination elevates circulating serum IGF-1 levels stably over time without causing pituitary atrophy, as the feedback loops governing native hormone production remain intact.
What Is the CJC-1295 Ipamorelin GH Stack Used for in Research?
In modern endocrinology, metabolic profiling and regenerative cell culture studies, the CJC-1295 Ipamorelin 10mg stack is evaluated across several primary investigative areas:
1. Nitrogen Retention & Protein Synthesis
Researchers examine how elevated IGF-1 signaling accelerates amino acid transport and myofibrillar protein synthesis in muscle tissue models.
2. Lipolysis & Adipose Tissue Oxidation
Evaluates how elevated GH pulses upregulate hormone-sensitive lipase (HSL), accelerating free fatty acid mobilization from visceral fat stores.
3. Connective Tissue & Collagen Density
Studies track systemic extracellular matrix remodeling, collagen turnover, and bone mineral density shifts under secretagogue-driven IGF-1 elevation.
Observed Research Benefits & Experimental Limits
Key Synergistic Benefits
- Supra-Additive GH Release: Dual GHRH + Ghrelin receptor activation produces significantly higher GH pulse height than single agents.
- High Selectivity Profile: Does not elevate serum Cortisol, Prolactin, or ACTH levels during testing.
- Preserved Pituitary Health: Natural pulsatile decay prevents receptor desensitization and pituitary shutdown.
Potential Handling Limitations
- Reconstitution Sensitivity: Peptide chains require gentle liquid addition down the glass wall to prevent mechanical shearing.
- Temperature Vulnerability: Solubilized liquid phases lose bioactivity if kept at room temperature for extended periods.
Laboratory Handling & Storage Instructions
Storage Recommendations
- Freeze-Dried Powder (Unopened): Store unopened vials in a laboratory freezer at -20°C to -80°C for long-term stability up to 24 months. Keep protected from direct light.
- Transport Resilience: Lyophilized powder remains stable during ambient transit conditions up to 25°C for up to 3 weeks.
- Reconstituted Liquid Phase: Store under refrigeration between 2°C and 8°C. Exhaust active testing liquid within 10 to 14 days maximum. Do not refreeze liquid solutions.
Step-by-Step Reconstitution Protocol
- Allow the 10mg vial to reach ambient room temperature naturally before opening the cap to eliminate condensation moisture inside the glass.
- Sanitize the rubber entry stopper with a fresh isopropyl alcohol wipe.
- Slowly introduce 1ml to 2ml of sterile bacteriostatic water down the inside glass wall of the vial.
- Do not shake. Gently swirl horizontally in small circles until the cake completely dissolves into a clear liquid.
Where Can I Buy a CJC-1295 Ipamorelin GH Stack 10mg for Research?
When searching to buy CJC-1295 Ipamorelin 10mg online or reviewing competitive CJC Ipamorelin price rates, verifying third-party tested analytical quality is essential for accurate secretagogue testing. Substandard peptide blends containing improper ratio balances or residual reagents can yield inaccurate endocrine data.
Every lot of our CJC Ipamorelin USA inventory undergoes independent High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (LC-MS) testing to confirm sequence identity and guarantee a certified purity baseline of ≥98.0%. To order CJC-1295 Ipamorelin for sale in high-grade 10mg vials backed by lot-matched COA documentation and fast domestic delivery, place your order directly through peptidesk.com.
Analytical Verification & COA Reports: Inspect our latest batch-specific HPLC purity charts, mass spectrometry results, and independent COA documents directly on our PeptidesK Third-Party Lab Testing Page.
Shop by Research Goals
Explore our catalog of analytical-grade compounds grouped by primary experimental targets:
| Category | Primary Research Focus |
|---|---|
| Muscle Growth & Building Peptides → | Anabolic signaling, GH secretagogues, and protein synthesis acceleration. |
| Anti-Aging & Longevity Peptides → | Cellular renewal, telomere maintenance, and anti-senescence research models. |
| Fat Loss & Metabolic Peptides → | Incretin mimetics, lipolysis acceleration, and metabolic flexibility profiling. |
| Recovery & Healing Peptides → | Soft tissue repair, tendon-to-bone recovery, and systemic cell migration. |
| Focus & Cognitive Peptides → | Nootropic signaling, neuroprotection, and synaptic plasticity assays. |






There are no reviews yet.